118 HRES 1330 IH: Supporting the goals and ideals of Alzheimer’s and Brain Awareness Month. U.S. House of Representatives 2024-06-28 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

IV118th CONGRESS2d SessionH. RES. 1330IN THE HOUSE OF REPRESENTATIVESJune 28, 2024Ms. Barragán (for herself, Mr. Buchanan, Ms. Sánchez, Mr. Bilirakis, Mr. Fitzpatrick, Mr. Tonko, Mr. Connolly, Mr. Lynch, Ms. Norton, Ms. Adams, Mr. Dunn of Florida, Mrs. Cammack, Ms. Wasserman Schultz, Ms. Bonamici, Ms. Tenney, Mr. Thanedar, Mr. Carey, Mr. Pascrell, Mr. Carter of Georgia, Ms. Craig, Mrs. Watson Coleman, Mr. Armstrong, Ms. Stevens, Mrs. Hayes, Mr. Garamendi, Mrs. Miller of West Virginia, Mr. Johnson of Georgia, Ms. Malliotakis, Mr. Balderson, Mr. Schneider, Ms. Sewell, Mr. Veasey, Ms. Spanberger, Mr. Phillips, Ms. Caraveo, Mr. Williams of New York, Mr. LaHood, Ms. Schakowsky, and Mr. Fong) submitted the following resolution; which was referred to the Committee on Energy and CommerceRESOLUTIONSupporting the goals and ideals of Alzheimer’s and Brain Awareness Month.

Whereas Alzheimer’s disease is a slow, progressive disorder of the brain that results in loss of memory and other cognitive function and, eventually, death; Whereas Alzheimer’s disease is the seventh leading cause of death in the United States and the fifth leading cause of death for persons aged 65 and over; Whereas nearly 7,000,000 Americans in the United States are living with Alzheimer’s disease, and this number may increase to 13,000,000 by the year 2050; Whereas almost two-thirds of those living with Alzheimer’s disease are women; Whereas it is estimated that 1 in 3 older Americans dies with Alzheimer’s disease or another dementia; Whereas Alzheimer’s disease is the only cause of death among the top 10 causes of death in the United States that has no means of prevention or cure; Whereas the direct costs to United States society of caring for Alzheimer’s disease patients in 2024 is estimated to be $360,000,000,000; Whereas over 11 million Americans provide unpaid care for people with Alzheimer’s disease or another dementia; Whereas nearly 70 percent of Alzheimer’s disease and dementia caregivers rate the emotional stress of caregiving as high or very high; Whereas nearly 40 percent of family caregivers for individuals living with Alzheimer’s disease and other forms of dementia report symptoms of depression; Whereas older Black Americans face nearly 2 times higher risk of developing Alzheimer’s disease; Whereas older Latinos face 1.5 times higher risk of developing Alzheimer’s disease; Whereas Asian Americans, Native Hawaiians, and Pacific Islanders are at high risk for underdetection of dementia and Alzheimer’s disease; Whereas every American is at risk for developing Alzheimer’s disease; Whereas stigma around having Alzheimer’s disease contributes to underdetection and failure to diagnose the disease; Whereas health disparities continue to exist for underserved populations, including Black, Latino, and Asian-American communities, in the care, caregiving, and research of Alzheimer’s disease; Whereas June is Alzheimer’s and Brain Awareness Month; Whereas the Alzheimer’s Association established Alzheimer’s and Brain Awareness Month in 2014, and the inaugural Alzheimer’s and Brain Awareness Month was celebrated in June of that year; and Whereas Alzheimer’s and Brain Awareness Month is an opportunity to— (1)raise awareness about Alzheimer’s disease and other forms of dementia; (2)advocate for Alzheimer’s disease and other forms of dementia research, care, and support services; and (3)offer support to individuals living with Alzheimer’s disease and other forms of dementia, their families, and their caregivers: Now, therefore, be it

That the House of Representatives— (1)supports the goals and ideals of Alzheimer’s and Brain Awareness Month; and (2)encourages people in the United States to— (A)educate themselves about Alzheimer’s disease and other forms of dementia; (B)advocate for Alzheimer’s disease research, care, and support services; and (C)offer their support to individuals living with Alzheimer’s disease and other forms of dementia, their families, and their caregivers.